FAQs: SAVING LIVES AND LIVELIHOODS

  • Version
  • Download 13487
  • File Size 1.54 MB
  • File Count 4
  • Create Date 16 July 2021
  • Last Updated 22 April 2022

FAQs: SAVING LIVES AND LIVELIHOODS

The Africa Centres for Disease Control and Prevention (Africa CDC) Programme to Support Member States to Rollout COVID-19 Vaccinations Supported by Mastercard Foundation

 

Clarification Questions and Answers

Attached Files

FileAction
Information Session - ENDownload
Information Session - FRDownload
Frequently Asked Questions (FAQs) - ENDownload
Frequently Asked Questions (FAQs) - FRDownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload